182 results
Page 5 of 10
424B5
4ywd5uk5sjjck4glq66
10 Jun 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
d81v7fltxl3p2p
5 May 20
Catalent, Inc. Reports Third Quarter Fiscal 2020 Results
7:32am
8-K
EX-99.1
f3hqxofg7e7
30 Apr 20
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
4:43pm
8-K
EX-4.1
rohxqxtqok8q 3i
3 Mar 20
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-99.1
jnwge iz3q0
20 Feb 20
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028
4:28pm
8-K
qiee3xvsj5jg cf
19 Feb 20
Catalent Announces Launch of Private Offering of €450 Million of Senior Unsecured Notes Due 2028
6:08am
8-K
EX-99.1
h4r6wgbzn4
19 Feb 20
Catalent Announces Launch of Private Offering of €450 Million of Senior Unsecured Notes Due 2028
6:08am
8-K
EX-99.1
6u71o
4 Feb 20
Catalent, Inc. Announces Pricing of Public Offering of Common Stock
12:00am
424B5
3d2mil y4e
3 Feb 20
Prospectus supplement for primary offering
4:26pm
8-K
EX-99.1
pvn8qli41ojaxz 0by
3 Feb 20
Catalent, Inc. Announces Public Offering of Common Stock
4:20pm
8-K
EX-2.1
kkkfdtuugihtv 7lj
3 Feb 20
Catalent, Inc. Reports Second Quarter Fiscal 2020 Results
7:40am
8-K
EX-99.2
tbr gv06coyslsd0p
3 Feb 20
Catalent, Inc. Reports Second Quarter Fiscal 2020 Results
7:40am
8-K
sfo3td98t7z1i1df
3 Feb 20
Catalent, Inc. Reports Second Quarter Fiscal 2020 Results
7:40am
8-K
EX-99.1
1is2939vnilz7
3 Feb 20
Catalent, Inc. Reports Second Quarter Fiscal 2020 Results
7:40am
8-K
EX-99.1
8ensta3c hc5
5 Nov 19
Catalent, Inc. Reports First Quarter Fiscal 2020 Results
7:33am